SEC 13F Intelligence

Phase 2 Partners, LLC / CME

Phase 2 Partners, LLC’s Cme Group Inc Position

Does Phase 2 Partners, LLC own Cme Group Inc (CME)? Not currently — the last reported position was 25.8K shares worth $6M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$6M
Q3 2024
Shares
25.8K
% of Portfolio
+3.36%
Quarters Held
5
position exited

Position History CME

Reported value by quarter
Q4 ’21: $4MQ4 ’21Q1 ’22: $956,000Q1 ’22Q1 ’23: $20MQ1 ’23Q2 ’23: $327,037Q2 ’23Q3 ’24: $6MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202425.8K$6M+3.36%
Q2 20231.8K$327,037+0.15%
Q1 2023104.2K$20M+8.60%
Q1 20224.0K$956,000+0.62%
Q4 202119.5K$4M+2.76%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Phase 2 Partners, LLC’s full portfolio or all institutional holders of CME.